title: Contributions of cell kill and posttreatment tumor growth rates to the repopulation of intracerebral 9L tumors after chemotherapy: an MRI study.
abstract: The drought of progress in clinical brain tumor therapy provides an impetus for developing new treatments as well as methods for testing therapeutics in animal models. The inability of traditional assays to simultaneously measure tumor size, location, growth kinetics, and cell kill achieved by a treatment complicates the interpretation of therapy experiments in animal models. To address these issues, tumor volume measurements obtained from serial magnetic resonance images were used to noninvasively estimate cell kill values in individual rats with intracerebral 9L tumors after treatment with 0.5, 1, or 2 x LD10 doses of 1,3-bis(2-chloroethyl)-1-nitrosourea. The calculated cell kill values were consistently lower than those reported using traditional assays. A dose-dependent increase in 9L tumor doubling time after treatment was observed that significantly contributed to the time required for surviving cells to repopulate the tumor mass. This study reveals that increases in animal survival are not exclusively attributable to the fraction of tumor cells killed but rather are a function of the cell kill and repopulation kinetics, both of which vary with treatment dose.
authors.affiliation: Department of Radiology, University of Michigan Medical Center, 1150 W. Medical Center Drive, Medical Science Research Building III, Room 9303, Ann Arbor, MI 48109-0648, USA. bdross@i,umich.edu
authors.forename: B D
authors.initials: BD
authors.lastname: Ross
authors.forename: Y J
authors.initials: YJ
authors.lastname: Zhao
authors.forename: E R
authors.initials: ER
authors.lastname: Neal
authors.forename: L D
authors.initials: LD
authors.lastname: Stegman
authors.forename: M
authors.initials: M
authors.lastname: Ercolani
authors.forename: O
authors.initials: O
authors.lastname: Ben-Yoseph
authors.forename: T L
authors.initials: TL
authors.lastname: Chenevert
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D002330:Carmustine / Q000627:therapeutic use*; D016923:Cell Death; D002455:Cell Division; D008279:Magnetic Resonance Imaging; D008297:Male; D008954:Models, Biological; D008962:Models, Theoretical; D009374:Neoplasms, Experimental / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology*; D011859:Radiography; D051381:Rats; D011916:Rats, Inbred F344
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002330:Carmustine